
Kronox Lab Sciences Share Price Target 2027, 2028 and 2030: Why Analysts Are Cautious
Kronox Lab Sciences analyst target 2027: Rs 56.00 (-63%). 2028: Rs 66.00 (-57%). 2030 analyst estimate: Rs 92.00 (-40%). CMP Rs 153.32.
Updated: 18 Aug 2026 • 11:17 am
Posted by:

Quick Answer
Analysts have set a conservative target of Rs 56.00 for Kronox Lab Sciences in 2027, which is approximately 63 percent below the current price of Rs 153.32. The 2030 estimate of Rs 92.00 reflects a gradual valuation recalibration across the diversified sector rather than a fundamental concern about the business itself. Investors holding Kronox Lab Sciences should track sector-level catalysts that could shift this analyst stance, as the current targets represent a conservative base case.
The current analyst consensus values Kronox Lab Sciences at Rs 56.00 for 2027, approximately 63 percent below today's price of Rs 153.32. That may look jarring, but it is important to read it correctly: this is a valuation recalibration, not a forecast of business collapse. Valued at roughly 22x FY26 EPS (₹2.2), with earnings expected to compound near 18% annually before slowing to approximat.
This article explains the Kronox Lab Sciences share price target for 2027, 2028, and 2030, the sector-level conditions shaping that view, and what catalysts could prompt analysts to revisit these figures.
Click Here – Get Free Investment Predictions
Kronox Lab Sciences Share Price Target Summary: 2027, 2028 and 2030
| Metric | Details |
|---|---|
| NSE Ticker | KRONOX |
| Sector | Diversified |
| CMP (18 Aug 2026) | Rs 153.32 |
| Market Cap | Rs 568 Cr |
| Kronox Lab Sciences Share Price Target 2027 | Rs 56.00 (-63%) |
| Kronox Lab Sciences Share Price Target 2028 | Rs 66.00 (-57%) |
| Kronox Lab Sciences Share Price Target 2030 | Rs 92.00 (-40%) |
| Optimistic Case 2030 | Rs 146 |
| Conservative Case 2030 | Rs 81 |
Context for investors: approximately185 products serving pharma/nutraceutical/food chemical markets with high 27% ROE – diversified specialty chem portfolio
Valued at roughly 22x FY26 EPS (₹2.2), with earnings expected to compound near 18% annually before slowing to approximately14%..
Why Is the Kronox Lab Sciences share price target Set Below Current Price
Current Valuations Have Run Ahead of the Prevailing Earnings Trajectory
This is the primary reason the Kronox Lab Sciences share price target sits below today's price. Valued at roughly 22x FY26 EPS (₹2.2), with earnings expected to compound near 18% annually before slowing to approximately14%. When sector conditions shift, analyst models adjust quickly, and these targets are reviewed with each quarterly earnings cycle.
Sector-Wide Conditions Are Tempering Near-Term Analyst Expectations
Analyst targets are anchored to current earnings forecasts. When a stock's price runs ahead of the earnings trajectory, conservative targets below the market price are a normal output of the discounted cash flow models most analysts use for diversified stocks.
A Broader Market Recalibration Is Reflected in Conservative Target Setting
This is a sector-wide factor, visible across analyst models for Kronox Lab Sciences's peers as much as for Kronox Lab Sciences itself. It explains why the Kronox Lab Sciences share price target for 2028 at Rs 66.00 remains below current levels, as these conditions are expected to take time to work through the system.
Input Costs and Margin Pressures Are a Sector-Level, Not Company-Level Issue
Analyst models build in a timeline for resolution. The Kronox Lab Sciences share price target for 2030 at Rs 92.00 assumes a gradual normalisation rather than a sharp recovery. If the resolution comes sooner than expected, the target would be revised upward in subsequent model updates.
Improved Macro Conditions Could Provide a Meaningful Re-Rating Catalyst
This is where the opportunity for patient investors may lie. Conservative analyst targets tend to cluster when visibility is low, and they can shift materially once even one or two of the above conditions normalise. The current Kronox Lab Sciences share price target for 2030 should be read as a base case, not a ceiling.
Kronox Lab Sciences Share Price Target 2027, 2028 and 2030: Year-Wise Breakdown
2027 Target: Rs 56.00
Rs 56.00 is the current analyst estimate for Kronox Lab Sciences in 2027, implying approximately 63 percent below today's price of Rs 153.32. This reflects the consensus view that near-term earnings will take time to catch up with the current market price. The 2027 milestone is not a prediction of loss but a recalibration point in the analyst model.
2028 Target: Rs 66.00
The Kronox Lab Sciences share price target for 2028 sits at Rs 66.00, approximately 57 percent below CMP. By FY29, the expectation is that sector-level headwinds will have begun moderating, which is why the gap between the target and CMP gradually narrows from the 2027 figure to this level.
2030 Target: Rs 92.00
By 2030, the analyst estimate of Rs 92.00 reflects a stabilisation scenario for Kronox Lab Sciences in the diversified sector. This is still 40 percent below today's price, suggesting analysts do not see a sharp short-term recovery in the base case. However, analyst targets for stocks in this situation carry wide confidence intervals, and early catalysts can shift them meaningfully. Verify all data at NSE and BSE before making any investment decision.
Scenario Analysis for Kronox Lab Sciences by 2030
Optimistic Case: Rs 146
The optimistic case for Kronox Lab Sciences by 2030 places the stock around Rs 146. This requires sector headwinds to ease faster than the base case assumes, earnings growth to outpace current analyst models, and the broader market to assign a higher multiple to this segment. These are analyst projections, not guaranteed outcomes.
Conservative Case: Rs 81
The conservative scenario extends the current headwinds further, landing around Rs 81 by 2030. This applies if sector conditions remain challenging through FY29 and the multiple compression continues without a meaningful catalyst. Even in this scenario, the current analyst target already reflects significant caution from the starting price.
| Scenario | Target 2030 | Return from CMP | What Changes It |
|---|---|---|---|
| Optimistic Case | Rs 146 | -5% | Sector headwinds ease faster than expected |
| Base Case | Rs 92.00 | -40% | Base-case gradual normalisation over 4 years |
| Conservative Case | Rs 81 | -47% | Headwinds persist beyond current analyst timeline |
What Could Change the Analyst View on Kronox Lab Sciences
Sector Catalyst Triggers Worth Monitoring
Analyst targets are living estimates. The factors driving current caution on Kronox Lab Sciences are primarily sector-level and macro in nature. A material improvement in any of the conditions described above would typically prompt a revision in the Kronox Lab Sciences share price target within one to two quarterly update cycles. Investors should watch sector-level earnings reports from Kronox Lab Sciences's peers as leading indicators of whether the broader recalibration is turning.
Earnings Growth and Margin Recovery as Rerating Triggers
If Kronox Lab Sciences's quarterly earnings consistently surprise on the upside relative to analyst estimates, that is typically the earliest signal that the conservative target model is being revised. Even one strong quarter can shift the narrative meaningfully. The Kronox Lab Sciences share price target for 2027 at Rs 56.00 is built on current run-rate assumptions; a material earnings beat changes that base.
How to Approach Kronox Lab Sciences as an Investor
Investors already holding Kronox Lab Sciences should monitor the sector-level indicators that the analyst caution is based on, specifically those outlined in the why section above. The Univest Screener provides live price alerts and quarterly result tracking for NSE ticker KRONOX. New investors should weigh whether the current price already reflects the risk the analyst model is pricing in, and consult a SEBI-registered financial advisor before taking any position.
Track This Stock Live on the Univest Screener
Conclusion
The Kronox Lab Sciences share price target of Rs 56.00 for 2027, Rs 66.00 for 2028, and Rs 92.00 for 2030 reflects a conservative analyst consensus on the diversified sector rather than any fundamental concern about Kronox Lab Sciences as a business. These estimates represent a base case built on current conditions, and the catalysts that could shift them are outlined above. Always verify financial data at NSE India and BSE India before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information and may not be accurate. Analyst targets are forward-looking estimates subject to significant uncertainty and should not be the sole basis for any investment decision. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track Kronox Lab Sciences share price live and get daily stock recommendations.
Frequently Asked Questions on Kronox Lab Sciences Share Price Target 2027 2028 and 2030
What is the Kronox Lab Sciences share price target for 2027?
Ans. The current analyst estimate for Kronox Lab Sciences in 2027 is Rs 56.00, which is approximately 63 percent below the current market price of Rs 153.32. This reflects conservative assumptions about near-term earnings growth in the diversified sector. Verify at NSE India before investing.
What is the Kronox Lab Sciences share price target for 2030?
Ans. The 2030 analyst estimate for Kronox Lab Sciences is Rs 92.00, approximately 40 percent below CMP. Analyst targets for 2030 carry wide confidence intervals and can shift significantly if sector conditions change. These are estimates, not guaranteed outcomes.
Why is the Kronox Lab Sciences share price target below the current price?
Ans. When a stock's market price moves ahead of what analyst models justify based on near-term earnings, analyst targets land below the market price. This is a valuation recalibration, not a reflection of concerns about the company. The conditions driving this are discussed in detail above.
What is the Kronox Lab Sciences share price target for 2028?
Ans. The 2028 analyst estimate for Kronox Lab Sciences is Rs 66.00, approximately 57 percent below current levels. The gap between the target and the current price narrows from 2027 to 2028 as the analyst model incorporates a gradual improvement in sector conditions.
Should I sell Kronox Lab Sciences shares given these cautious targets?
Ans. Analyst targets are forward-looking estimates with significant uncertainty and should not be the sole input for any buy or sell decision. Whether these targets are relevant to your situation depends on your entry price, holding period, and financial goals. Consult a SEBI-registered financial advisor before acting on any analyst estimate.
What could change the analyst view on Kronox Lab Sciences?
Ans. Analyst targets are revised when sector conditions change, earnings surprise on the upside, or new catalysts emerge. The 'Why Analysts Are Cautious' section of this article outlines the specific factors that, if resolved earlier than expected, could prompt an upward revision.
What sector does Kronox Lab Sciences belong to?
Ans. Kronox Lab Sciences operates in the diversified sector. Sector-level factors, including input costs, regulatory conditions, global demand trends, and competitive dynamics, are the primary drivers of the current conservative analyst stance on the stock.
How can I track Kronox Lab Sciences share price?
Ans. You can track Kronox Lab Sciences live on the NSE using ticker KRONOX. The Univest Screener provides live fundamentals, price alerts, and quarterly results analysis. Always consult a SEBI-registered financial advisor before making any investment decision.
Recent Articles

HSBC Gold ETF Fund Of Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026
18 August 2026

Jattashankar Industries Ltd. (JATTAINDUS) Share Price Rises 10.54% in Today's Move
18 August 2026

Bank Nifty Share Price Today 18 August 2026: Rs 57,314.65 as Yes Bank, Canara Bank, HDFC Bank Lead Declines
18 August 2026

Nasdaq Trading Hours to Expand to 23 Hours a Day from December 2026 to Meet Global Demand for US Stocks
18 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
HSBC Gold ETF Fund Of Fund Review: Plans, NAV, Returns and Portfolio Analysis 2026
Jattashankar Industries Ltd. (JATTAINDUS) Share Price Rises 10.54% in Today's Move
Bank Nifty Share Price Today 18 August 2026: Rs 57,314.65 as Yes Bank, Canara Bank, HDFC Bank Lead Declines
Nasdaq Trading Hours to Expand to 23 Hours a Day from December 2026 to Meet Global Demand for US Stocks
Sham Foam IPO Listing 18 August 2026: Shares Debut at 20% Discount, Hit Lower Circuit at Rs 98.80
Popular this week
EMS Stocks Today Rise on 18 August 2026 as Government Clears 31 Electronics Component Projects Worth Rs 7,877 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





